February 25, 2021Open Access

Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma

Los puntos clave no están disponibles para este artículo en este momento.

Compared to PL, HPL was associated with a significantly better treatment response and survival benefits for patients with advanced HCC.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Mei et al. (Thu,) studied this question.

Me gusta

Guardar

Ver artículo completo